• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA CH 930 CREATININE_2 (CREA_2); ALKALINE PICRATE, COLORIMETRY, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA CH 930 CREATININE_2 (CREA_2); ALKALINE PICRATE, COLORIMETRY, CREATININE Back to Search Results
Model Number N/A
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/09/2023
Event Type  malfunction  
Event Description
The customer obtained a falsely depressed creatinine_2 (crea_2) result on a patient sample on an atellica ch 930 analyzer, serial number (s/n): (b)(6).The initial result was reported to the physician, who questioned the result.The sample was retested, and a higher result was obtained.The retest result was reported as the correct result to the physician.There are no known reports of patient intervention or adverse health consequences due to falsely depressed crea_2 result.
 
Manufacturer Narrative
An outside of the united states (ous) customer contacted siemens customer care center to report an observation of a falsely depressed atellica ch 930 creatinine_2 (crea_2) result.Siemens investigated the issue.The instrument data and complaint documentation were reviewed, and the following was noted: results data shows the crea_2 method was calibrated on (b)(6)2023 utilizing reagent pack/well 1, 12130, 22180210032223100102497, 1, 12130, 2218022003222310.The calibration was acceptable, and quality control (qc) run on this reagent pack/well and an alternate one (0, 12143, 22180210032223100102493, 0, 12143, 2218022003222310) that was on board at the time was within acceptable limits indicating the method was working as intended.Patient result was generated from reagent pack/well 0, 12130, 22180210032223100102497, 0, 12130, 2218022003222310.Qc was not run on this well prior to patient testing.Qc was run later in the day at approximately 1755 local time after the discordant results were generated and the qc was low and out of acceptable limits.The alternate reagent well that was opened and onboard was qc'ed at the same time and generated acceptable results.This indicates that the issue was isolated to the one well set.Process error logs show there were 7343 errors associated with the reagent loader arm and reagent manual load station between (b)(6)2023.The last error occurred at approximately 0956 local time prior to the discordant result being generated.Reagent event data shows reagent pack/well 0, 12130, 22180210032223100102497, 0, 12130, 2218022003222310 was opened during the time the reagent loader was having issues on 6/6/2023.Level sense data and aspiration pressure profiles were reviewed and there were no abnormalities.The data from theses queries and analysis indicates the reagent arms, sample arm, and dilution arm were functioning as intended without error and there were no issues with aspirating/dispensing reagent or sample.Based on review of all the data, siemens has determined the probable cause was due to a potentially contaminated reagent well.Qc performed on subsequent wells shows the issue was isolated to the one well set.A product performance issue has not been identified.The customer is operational.The interpretation of results section of the instructions for use states: "results of this assay should always be interpreted in conjunction with the patient¿s medical history, clinical presentation, and other findings.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA CH 930 CREATININE_2 (CREA_2)
Type of Device
ALKALINE PICRATE, COLORIMETRY, CREATININE
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict ave
tarrytown NY 10591
Manufacturer (Section G)
RANDOX LABORATORIES LTD.
55 diamond road
registration # 8020890
crumlin co. antrim BT29 4Q
UK   BT29 4Q
Manufacturer Contact
stacy loukos
333 coney st.
east walpole, MA 02032
3392064073
MDR Report Key17287244
MDR Text Key319401871
Report Number1219913-2023-00130
Device Sequence Number1
Product Code CGX
UDI-Device Identifier00630414596457
UDI-Public00630414596457
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K161494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 07/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/01/2023
Device Model NumberN/A
Device Catalogue Number11097596
Device Lot Number221802
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/14/2023
Initial Date FDA Received07/10/2023
Date Device Manufactured07/01/2022
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age60 YR
Patient SexMale
-
-